These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3836718)

  • 1. Mammography and the value of screening.
    Whitehouse GH
    Br J Hosp Med; 1985 Nov; 34(5):263. PubMed ID: 3836718
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mass screening for breast cancer: remaining questions].
    Verbeek AL
    Ned Tijdschr Geneeskd; 1987 Sep; 131(37):1602-4. PubMed ID: 3670448
    [No Abstract]   [Full Text] [Related]  

  • 3. Mammography uncovers 90% of breast cancers.
    Dugan WM
    J Indiana State Med Assoc; 1982 Oct; 75(10):734, 760. PubMed ID: 7142732
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of service screening mammography on population mortality from breast carcinoma.
    Feig SA
    Cancer; 2002 Aug; 95(3):451-7. PubMed ID: 12209736
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast cancer screening in Sweden. The single modality approach.
    Andersson I; Fagerberg G; Lundgren B; Tabár L
    Radiologe; 1980 Dec; 20(12):608-11. PubMed ID: 7208897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
    Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
    J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the dissemination of mammography in the United States.
    Cronin KA; Yu B; Krapcho M; Miglioretti DL; Fay MP; Izmirlian G; Ballard-Barbash R; Geller BM; Feuer EJ
    Cancer Causes Control; 2005 Aug; 16(6):701-12. PubMed ID: 16049809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammographic screening of women aged 40 to 49 years. Is it justified?
    Feig SA
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):587-606. PubMed ID: 7731636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Theoretical value and practical applicability of mass screening for carcinoma of the breast].
    De Felice C; Falqui L; Lodolini G; Luciani S; Meggiorini ML; Nusiner MP; Pozzi V
    Minerva Ginecol; 1984 Nov; 36(11):727-31. PubMed ID: 6527827
    [No Abstract]   [Full Text] [Related]  

  • 10. European Society of Mastology Consensus conference on breast cancer screening Paris, 4-5 February, 1993. Report of the evaluation committee.
    Wald N; Chamberlain J; Hackshaw A
    Bull Cancer; 1994 Apr; 81(4):251-9. PubMed ID: 7703543
    [No Abstract]   [Full Text] [Related]  

  • 11. European Society of Mastology. Consensus Conference on Breast Cancer Screening. Paris, 4-5 February, 1993. Report of the Evaluation Committee.
    Wald NJ; Chamberlain J; Hackshaw A
    Bull Cancer; 1994 Oct; 81(10):825-34. PubMed ID: 7734765
    [No Abstract]   [Full Text] [Related]  

  • 12. A statistical evaluation of mammography: crucial questions for health systems.
    Watson CJ; Chesteen SA
    J Soc Health Syst; 1993; 4(1):68-79. PubMed ID: 8268470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening mammography: the Mount Sinai BreastCheck experience.
    Moskowitz H; Kron E; Hall D
    Conn Med; 1993 Dec; 57(12):777-80. PubMed ID: 8149736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of women with familial risk of breast cancer.
    Boetes C
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):97-101. PubMed ID: 12585662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening mammography for women ages 40 to 49 years.
    Timins JK
    N J Med; 1997 Apr; 94(4):39-43. PubMed ID: 9108723
    [No Abstract]   [Full Text] [Related]  

  • 17. [Breast cancer screening is efficient and useful from the age of forty].
    Tristant H
    Gynecol Obstet Fertil; 2004; 32(7-8):659-63. PubMed ID: 15450267
    [No Abstract]   [Full Text] [Related]  

  • 18. A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer.
    Duijm LE; Groenewoud JH; Roumen RM; de Koning HJ; Plaisier ML; Fracheboud J
    Breast Cancer Res Treat; 2007 Nov; 106(1):113-9. PubMed ID: 17219049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent controversies in mammography screening for breast cancer.
    McTiernan A
    Medscape Womens Health; 2002; 7(2):3. PubMed ID: 12142859
    [No Abstract]   [Full Text] [Related]  

  • 20. [Distressed or relieved? Psychological sequelae of breast cancer screening in Netherlands].
    van Wijngaarden DA
    Ned Tijdschr Geneeskd; 1999 Apr; 143(16):873-4. PubMed ID: 10347659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.